RGNX Regenxbio announces pricing of public offering of common stock and pre-funded warrants Regenxbio - expects gross proceeds of about $100

RGNX Regenxbio announces pricing of public offering of common stock and pre-funded warrants Regenxbio - expects gross proceeds of about $100M from offering - Prices public offering of 10M shares at $9 and 1.11M pre-funded warrants at $9 - Offering expected to close on July 20, 2026